In late August, in time for the fall season, the Food and Drug Administration authorized and approved updated COVID-19 ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

S eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season.

A new retrospective cohort study conducted in Dubai shows that the antiviral nirmatrelvir plus ritonavir, sold as Paxlovid, ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 ...

COVID-19 Contagiousness Over Time How long you are ... antibodies you have from previous infection or vaccination. The Omicron variant has 26 spike protein mutations, allowing for more subvariants ...

The new Omicron variant is expected to infect 60 per cent of people in China in the coming three months. Symptoms of COVID-19 can range from mild to severe, and can include fever, cough ...

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three vaccines available in the U.S.

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. Experts worry the unusual move, driven by vaccine ...